article thumbnail

COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation

Healthcare IT Today

The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology. In conjunction, COTA announced it has raised additional capital from existing investors. COTA Adds Emerging Types of Data to Oncology Real-World Data Platform.

article thumbnail

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Lloyd Price

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? A framework called the "Taker-Shaper-Maker" model can be used to describe how organisations can adopt generative AI.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Weekly Roundup – October 1, 2022

Healthcare IT Today

In the latest CIO Podcast, Mark Weisman, MD of TidalHealth discussed how to successfully convert and decommission legacy data and systems as part of a move from Cerner to Epic. The organizations asked for a one-year delay, though it remains to be seen if ONC and HHS will honor the request.

eHealth 87
article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

It can test thousands of protocol variations and discover the optimal trial design for success, helping research and development (R&D) teams more accurately and rapidly predict clinical trial results and decide whether a trial should proceed, how to optimize cohorts, whether drugs can be repurposed, and other crucial factors.

article thumbnail

Coronavirus: Don’t Panic, Get Informed

American Well

While there’s still a lot that we don’t yet know about the disease, investigations into the virus and how it spreads are actively underway to best understand how to protect the public. So far, only five cases have been confirmed in the U.S., have been linked to people who traveled to the Wuhan area of China.

article thumbnail

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

Digital Health Global

We are applying our proprietary know-how to develop a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing. billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development.

article thumbnail

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

Further challenges exist in how virtual care is integrated into existing frameworks, how patients access it and how to ensure it can develop without bureaucratic delays. Digital health companies can help identify new drug targets, design clinical trials and analyse data more effectively.